It has also been observed that the expression of Cav1.3 subtypes increased in the brain of patients at early stage of the disease, even before the appearance of recognized pathological signs (Hurley et al., 2013), suggesting that Ca2+ dysregulation could be an early event in PD pathogenesis. Here, CACNA1D is linked to Parkinson disease.